Dr. Giorgos Constantine Karakousis, MD

Dr. Karakousis practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Karakousis' NPI, 1952458937, was assigned on January 4, 2007. Dr. Karakousis graduated from Perelman School of Med at the University of Pennsylvania in 2001. Dr. Karakousis holds Pennsylvania license MD423324.

Dr. Karakousis' primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Karakousis' primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Karakousis is also affiliated with Pennsylvania Hospital. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Karakousis to 1 more hospital, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karakousis practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Karakousis' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Karakousis is licensed in Pennsylvania.

CMS data shows 868 Medicare services from Dr. Karakousis across 15 procedure codes in 2024, for 356 Medicare patients. Medicare paid $100,561 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 356 Medicare patients who saw Dr. Karakousis in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karakousis' median patient age at 67, with 50% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Karakousis for performance year 2024, reported as part of a group. Dr. Karakousis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Karakousis as offering telehealth. CMS counts 137 procedures of melanoma (skin cancer) excision by Dr. Karakousis, more than 95% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 325 papers to Dr. Karakousis, published from 2011 to 2025. 2022 was the busiest year, with 33. The most frequent topics are Melanoma, Skin Neoplasms and Sentinel Lymph Node Biopsy. Dr. Karakousis has published most often in Ann Surg Oncol. Dr. Karakousis' most frequent co-authors are John Thomas Miura, MD, Douglas Leon Fraker, MD and Robert Edward Roses, MD.

Dmand AI links Dr. Karakousis to 3 clinical trials. Conditions studied include Intestinal Obstruction, Melanoma and Peritoneal Neoplasms.

CMS Open Payments shows 25 general payments to Dr. Karakousis from 4 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 91% of the total. Merck Sharp & Dohme Corporation paid the most, $15,900.

Dr. Karakousis graduated from Perelman School of Med at the University of Pennsylvania in 2001.